Eyewire News: The Podcast
04.23.25
The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
01.07.26
Staar Terminates Merger with Alcon12.31.25
2025 Year in Review - Part 212.24.25
2025 Year in Review - Part 112.17.25
Update on Reproxalap PDUFA Timing11.18.25
Live Coverage of B+L Investor DayShow More